[
1. McCusker C, Upton J, Warrington R. Primary immunodeficiency. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):61-.10.1186/s13223-018-0290-5615716030275850
]Search in Google Scholar
[
2. Conley ME, Dobbs AK, Farmer DM, et al. Primary B cell immunodeficiencies: comparisons and contrasts. Annual review of immunology. 2009;27:199-227.10.1146/annurev.immunol.021908.13264919302039
]Search in Google Scholar
[
3. Winkelstein JA, Conley ME, James C, Howard V, Boyle J.(2008) Adults with X-linked agammaglobulinemia: impact of disease on daily lives, quality of life, educational and socioeconomic status, knowledge of inheritance, and reproductive attitudes. Medicine (Baltimore). 87(5):253-8.10.1097/MD.0b013e318187ed81283141118794707
]Search in Google Scholar
[
4. Bucciol G, Moens L, Payne K, et al. Chronic Aichi virus infection in a patient with x-linked agammaglobulinemia. Journal of clinical immunology. 2018;38(7):748-52.10.1007/s10875-018-0558-z30311057
]Search in Google Scholar
[
5. El-Sayed ZA, Abramova I, Aldave JC, Al-Herz W, Bezrodnik L, Boukari R.(2019) X-linked agammaglobulinemia (XLA):Phenotype, diagnosis, and therapeutic challenges around the world. World Allergy Organ J.12(3):100018.10.1016/j.waojou.2019.100018643940330937141
]Search in Google Scholar
[
6. Zheng B, Zhang Y, Jin Y, Yu H. A novel Bruton’s tyrosine kinase gene (BTK) missense mutation in a Chinese family with X-linked agammaglobulinemia. BMC pediatrics. 2014;14(1):265.10.1186/1471-2431-14-265428693425316352
]Search in Google Scholar
[
7. Garmendia J, Gonzalo-Asensio J. Editorial: Update on the Immune Mechanisms Against Respiratory Pathogens. Front Immunol. 2019;10:1730-.10.3389/fimmu.2019.01730666408231396232
]Search in Google Scholar
[
8. Suri D, Rawat A, Singh S. X-linked Agammaglobulinemia. The Indian Journal of Pediatrics. 2016;83(4): 331-7.10.1007/s12098-015-2024-826909497
]Search in Google Scholar
[
9. Jawhara S. Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? Int J Mol Sci. 2020;21(7):2272.10.3390/ijms21072272717825032218340
]Search in Google Scholar
[
10. Sallard E, Lescure F-X, Yazdanpanah Y, Mentre F, Peiffer-Smadja N. Type 1 interferons as a potential treatment against COVID-19. Antiviral Res. 2020;178:104791-.10.1016/j.antiviral.2020.104791713838232275914
]Search in Google Scholar
[
11. Trouillet-Assant S, Viel S, Gaymard A, et al. Type I IFN immunoprofiling in COVID-19 patients. J Allergy Clin Immunol. 2020:S0091-6749(20)30578-9.
]Search in Google Scholar
